首页 › 基金 › TANAKA CAPITAL MANAGEMENT INC › CORT
TANAKA CAPITAL MANAGEMENT INC 对 CORT 的持仓历史
CORCEPT THERAPEUTICS INC · 医疗保健
TANAKA CAPITAL MANAGEMENT INC 在 Q1 2026 的 13F 申报中披露持有 CORT(CORCEPT THERAPEUTICS INC)110,854 股,市值约 US$4.5M,约占其申报组合的 7.46%,在其申报持仓中市值排名第 3 位。 TANAKA CAPITAL MANAGEMENT INC 最近 11 个申报季度中有 8 个季度披露了 CORT 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR
TANAKA CAPITAL MANAGEMENT INC 对 CORT 的持仓演变
TANAKA CAPITAL MANAGEMENT INC 于 Q3 2023 首次披露 CORT 持仓:37,569 股(约 US$1.0M)。 该持仓在 Q1 2025 达到峰值 93,184 股,市值约 US$10.6M。 在 8 次申报中,TANAKA CAPITAL MANAGEMENT INC 2 次增持、3 次减持、2 次保持不变。 最近一期申报(Q1 2026)显示持股 110,854 股、市值约 US$4.5M。 持仓曾出现大幅变动:Q3 2024 增持约 202% (随后一个季度股价上涨 9%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 37.57K | $1.02M | 新进 |
| Q4 2023 | 37.09K | $1.21M | 减持 |
| Q3 2024 | 112.14K | $5.19M | 增持 |
| Q4 2024 | 111.55K | $5.62M | 减持 |
| Q1 2025 | 93.18K | $10.64M | 减持 |
| Q3 2025 | 111.21K | $9.24M | 增持 |
| Q4 2025 | 111.08K | $3.87M | 持有 |
| Q1 2026 | 110.85K | $4.47M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CORT 与 13F 数据
CORT(CORCEPT THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 39 只申报持有 CORT,申报仓位最大的包括:文艺复兴科技 (US$457.5M), Parallel Advisors, LLC (US$344.5M), TANG CAPITAL MANAGEMENT LLC (US$130.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CORT 的基金
- 文艺复兴科技 5.26M 股 · $457.50M · Q2 2026
- Parallel Advisors, LLC 3.96M 股 · $344.51M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M 股 · $130.43M · Q2 2026
- MPM BioImpact LLC 771.03K 股 · $67.04M · Q2 2026
- EMERALD ADVISERS, LLC 748.33K 股 · $65.07M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 464.90K 股 · $40.42M · Q2 2026
- PERCEPTIVE ADVISORS LLC 398.38K 股 · $34.64M · Q2 2026
更多关于 TANAKA CAPITAL MANAGEMENT INC
常见问题
How long has TANAKA CAPITAL MANAGEMENT INC held CORT?
TANAKA CAPITAL MANAGEMENT INC has disclosed CORT holdings in 8 of the last 11 reported quarters, going back to Q3 2023.
What is TANAKA CAPITAL MANAGEMENT INC's current position in CORT?
As of Q1 2026, TANAKA CAPITAL MANAGEMENT INC holds 110.85K shares of CORT (CORCEPT THERAPEUTICS INC), valued at $4.47M, representing 7.46% of its reported portfolio and ranking #3.
Has TANAKA CAPITAL MANAGEMENT INC been buying or selling CORT?
In the latest 13F filing (Q1 2026), TANAKA CAPITAL MANAGEMENT INC held unchanged its position in CORT. The position peaked in Q1 2025 at 93.18K shares.
Which other funds hold CORT?
Other major institutional holders of CORT include 文艺复兴科技, Parallel Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.